{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T09:54:07Z","timestamp":1778925247576,"version":"3.51.4"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,7,4]],"date-time":"2019-07-04T00:00:00Z","timestamp":1562198400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,7,4]],"date-time":"2019-07-04T00:00:00Z","timestamp":1562198400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Gastric cancer (GC) is a heterogeneous disease, so molecular classification is important for selecting the most appropriate treatment strategies for GC patients. To be applicable in the clinic, there is an urgent need for a platform that will allow screening real-life archival tissue specimens. For this purpose, we performed RNA sequencing of 50 samples from our Asian Cancer Research Group (ACRG) GC cohort to reproduce the molecular subtypes of GC using archival tissues with different platforms. We filtered out genes from the epithelial-to-mesenchymal transition (EMT) and microsatellite instability-high (MSI) signatures (coefficient\u2009\u2264\u20090.4) followed by the ACRG molecular subtype strategy. Overall accuracy of reproduction of ACRG subtype was 66% (33\/50). Given the importance of EMT subtype in future clinical trials, we further developed the minimum number of genes (10 genes) for EMT signatures correlating highly with the original EMT signatures (correlation\u2009\u2265\u20090.65). Using our 10-gene model, we could classify EMT subtypes with high sensitivity (0.9576) and specificity (0.811). In conclusion, we reproduced ACRG GC subtypes using different platforms and could predict EMT subtypes with 10 genes and are now planning to use them in our prospective clinical study of precision oncology in GC.<\/jats:p>","DOI":"10.1038\/s41598-019-46216-6","type":"journal-article","created":{"date-parts":[[2019,7,4]],"date-time":"2019-07-04T14:24:03Z","timestamp":1562250243000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Reproduction of molecular subtypes of gastric adenocarcinoma by transcriptome sequencing of archival tissue"],"prefix":"10.1038","volume":"9","author":[{"given":"You Jeong","family":"Heo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5857-7695","authenticated-orcid":false,"given":"Charny","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Doyeong","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4911-6165","authenticated-orcid":false,"given":"Jeeyun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1162-9205","authenticated-orcid":false,"given":"Kyoung-Mee","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,7,4]]},"reference":[{"key":"46216_CR1","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1155\/2015\/896560","volume":"2015","author":"A Murphy","year":"2015","unstructured":"Murphy, A. & Kelly, R. J. From Molecular Classification to Targeted Therapeutics: The Changing Face of Systemic Therapy in Metastatic Gastroesophageal Cancer. Gastroenterology Research and Practice 2015, 11, https:\/\/doi.org\/10.1155\/2015\/896560 (2015).","journal-title":"Gastroenterology Research and Practice"},{"key":"46216_CR2","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/nrgastro.2017.33","volume":"14","author":"MF Bijlsma","year":"2017","unstructured":"Bijlsma, M. F., Sadanandam, A., Tan, P. & Vermeulen, L. Molecular subtypes in cancers of the gastrointestinal tract. Nature reviews. Gastroenterology & hepatology 14, 333\u2013342, https:\/\/doi.org\/10.1038\/nrgastro.2017.33 (2017).","journal-title":"Gastroenterology & hepatology"},{"key":"46216_CR3","doi-asserted-by":"publisher","unstructured":"Cancer Genome Atlas Research, N. Comprehensive molecular characterization of gastric adenocarcinoma. Nature 513, 202\u2013209, https:\/\/doi.org\/10.1038\/nature13480 (2014).","DOI":"10.1038\/nature13480"},{"key":"46216_CR4","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1038\/nm.3850","volume":"21","author":"R Cristescu","year":"2015","unstructured":"Cristescu, R. et al. Molecular analysis of gastric cancer identifies subtypes associated with distinct clinical outcomes. Nature medicine 21, 449\u2013456, https:\/\/doi.org\/10.1038\/nm.3850 (2015).","journal-title":"Nature medicine"},{"key":"46216_CR5","doi-asserted-by":"publisher","unstructured":"Lee, J. et al. Development of mesenchymal subtype gene signature for clinical application in gastric cancer. Oncotarget 8, 66305\u201366315, https:\/\/doi.org\/10.18632\/oncotarget.19985 (2017).","DOI":"10.18632\/oncotarget.19985"},{"key":"46216_CR6","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-04179-8","volume":"9","author":"SC Oh","year":"2018","unstructured":"Oh, S. C. et al. Clinical and genomic landscape of gastric cancer with a mesenchymal phenotype. Nature communications 9, 1777, https:\/\/doi.org\/10.1038\/s41467-018-04179-8 (2018).","journal-title":"Nature communications"},{"key":"46216_CR7","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1002\/1878-0261.12093","volume":"11","author":"S Terry","year":"2017","unstructured":"Terry, S. et al. New insights into the role of EMT in tumor immune escape. Molecular oncology 11, 824\u2013846, https:\/\/doi.org\/10.1002\/1878-0261.12093 (2017).","journal-title":"Molecular oncology"},{"key":"46216_CR8","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/j.ccell.2018.03.005","volume":"33","author":"R Zappasodi","year":"2018","unstructured":"Zappasodi, R., Merghoub, T. & Wolchok, J. D. Emerging Concepts for Immune Checkpoint Blockade-Based Combination Therapies. Cancer cell 33, 581\u2013598, https:\/\/doi.org\/10.1016\/j.ccell.2018.03.005 (2018).","journal-title":"Cancer cell"},{"issue":"9","key":"46216_CR9","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1038\/s41591-018-0101-z","volume":"24","author":"Seung Tae Kim","year":"2018","unstructured":"Kim, S. T. et al. Comprehensive molecular characterization of clinical responses to PD-1 inhibition in metastatic gastric cancer. Nature medicine, https:\/\/doi.org\/10.1038\/s41591-018-0101-z (2018).","journal-title":"Nature Medicine"},{"key":"46216_CR10","doi-asserted-by":"publisher","DOI":"10.1186\/1755-8794-4-9","volume":"4","author":"A Loboda","year":"2011","unstructured":"Loboda, A. et al. EMT is the dominant program in human colon cancer. BMC Medical Genomics 4, 9, https:\/\/doi.org\/10.1186\/1755-8794-4-9 (2011).","journal-title":"BMC Medical Genomics"},{"key":"46216_CR11","doi-asserted-by":"publisher","unstructured":"The Cancer Genome Atlas, N. Comprehensive molecular characterization of human colon and rectal cancer. Nature 487, 330, https:\/\/doi.org\/10.1038\/nature11252 https:\/\/www.nature.com\/articles\/nature11252#supplementary-information (2012).","DOI":"10.1038\/nature11252"},{"key":"46216_CR12","doi-asserted-by":"publisher","unstructured":"The Cancer Genome Atlas, N. Comprehensive molecular portraits of human breast tumours. Nature 490, 61, https:\/\/doi.org\/10.1038\/nature11412 https:\/\/www.nature.com\/articles\/nature11412#supplementary-information (2012).","DOI":"10.1038\/nature11412"},{"key":"46216_CR13","doi-asserted-by":"publisher","first-page":"4059","DOI":"10.1158\/0008-5472.can-04-3953","volume":"65","author":"H Dai","year":"2005","unstructured":"Dai, H. et al. A Cell Proliferation Signature Is a Marker of Extremely Poor Outcome in a Subpopulation of Breast Cancer Patients. Cancer Research 65, 4059\u20134066, https:\/\/doi.org\/10.1158\/0008-5472.can-04-3953 (2005).","journal-title":"Cancer Research"},{"issue":"1","key":"46216_CR14","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.ajpath.2011.03.007","volume":"179","author":"Domenico Coppola","year":"2011","unstructured":"Coppola, D. et al. Unique Ectopic Lymph Node-Like Structures Present in Human Primary Colorectal Carcinoma Are Identified by Immune Gene Array Profiling. The American Journal of Pathology 179, 37\u201345, https:\/\/doi.org\/10.1016\/j.ajpath.2011.03.007.","journal-title":"The American Journal of Pathology"},{"key":"46216_CR15","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1016\/j.csbj.2015.08.001","volume":"13","author":"X Lin","year":"2015","unstructured":"Lin, X., Zhao, Y., Song, W. M. & Zhang, B. Molecular classification and prediction in gastric cancer. Computational and structural biotechnology journal 13, 448\u2013458, https:\/\/doi.org\/10.1016\/j.csbj.2015.08.001 (2015).","journal-title":"Computational and structural biotechnology journal"},{"key":"46216_CR16","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1053\/j.gastro.2013.05.010","volume":"145","author":"Z Lei","year":"2013","unstructured":"Lei, Z. et al. Identification of molecular subtypes of gastric cancer with different responses to PI3-kinase inhibitors and 5-fluorouracil. Gastroenterology 145, 554\u2013565, https:\/\/doi.org\/10.1053\/j.gastro.2013.05.010 (2013).","journal-title":"Gastroenterology"},{"key":"46216_CR17","doi-asserted-by":"publisher","first-page":"194","DOI":"10.4251\/wjgo.v9.i5.194","volume":"9","author":"SK Garattini","year":"2017","unstructured":"Garattini, S. K. et al. Molecular classifications of gastric cancers: Novel insights and possible future applications. World journal of gastrointestinal oncology 9, 194\u2013208, https:\/\/doi.org\/10.4251\/wjgo.v9.i5.194 (2017).","journal-title":"World journal of gastrointestinal oncology"},{"key":"46216_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/s12864-015-2270-1","volume":"16","author":"W Li","year":"2015","unstructured":"Li, W. et al. Comprehensive evaluation of AmpliSeq transcriptome, a novel targeted whole transcriptome RNA sequencing methodology for global gene expression analysis. BMC genomics 16, 1069, https:\/\/doi.org\/10.1186\/s12864-015-2270-1 (2015).","journal-title":"BMC genomics"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-46216-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-46216-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-46216-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T11:10:13Z","timestamp":1671275413000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-46216-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,4]]},"references-count":18,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["46216"],"URL":"https:\/\/doi.org\/10.1038\/s41598-019-46216-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,4]]},"assertion":[{"value":"25 February 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 June 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"9675"}}